Our Team
Regulatory experts, industry innovators, and client collaborators bringing your medical device innovations to life.
Doug B. Constable
Chief Executive Officer
Doug Constable brings over 30 years of MedTech and manufacturing leadership to Life Science Outsourcing (LSO). As CEO, he leads the company’s next phase of growth under PPC Enterprises, expanding LSO’s integrated manufacturing, packaging, and sterilization capabilities. Before joining LSO, Doug served as CEO of Clayens North America and guided more than 40 strategic transactions across his career. Known for his results-driven leadership and commitment to operational excellence, Doug continues to advance LSO’s mission of helping innovators reach the market faster.
Neil A. Goldman, CPA
Chief Financial Officer
Neil Goldman brings decades of financial leadership experience, driving growth and strategic expansion across the diagnostics and manufacturing industries. At BioPorto A/S, he raised over DKK 140 million to support clinical trials and FDA review, and in prior roles at Chembio Diagnostics, J.S. Held, and Unwired Technology, he led revenue growth, acquisitions, and operational scaling. A graduate of Miami University with a B.S. in Business-Accountancy, Neil’s expertise positions LSO for continued success and innovation in the medical device manufacturing space.
Krista Precourt
Chief Operating Officer
Krista Precourt brings over 20 years of operational leadership in regulated manufacturing, with a strong track record of driving performance and execution. As COO, she oversees operations across all LSO locations, leading site execution, ERP integration, and strategic initiatives to improve quality, delivery, and profitability.
Since joining LSO in 2022, Krista has played a key role in unifying production systems and strengthening cross-functional operations.
She previously held senior roles at ECA Medical Instruments and Aveox Inc., and holds a degree in Business Administration from Ohio Northern University.
Ruben J. Osuna
Senior IT Manager
Work With Us
Our Commitment to D&I
What does D&I mean to LSO?
Why D&I matters to LSO now and in the future
How does LSO approach D&I? What does LSO have planned of the future?
Life Science Outsourcing strives for workforce diversity by developing, fostering, and advancing an inclusive culture within the organization.
Life Science Outsourcing D&I is driven by three essential pillars to ensure inclusivity in an expeditiously diverse world.
- Embracing a culture geared towards inclusivity and mutuality.
- Frame a Diverse workforce for LSO’s future.
- Promote innovative ideas and business advancement in the marketplace.